Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries
Tóm tắt
The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national guidelines in sub-Saharan Africa is poorly documented. We aimed to review national guidelines for AHD management across six selected countries in sub-Saharan Africa for benchmarking against the 2021 WHO recommendations. We reviewed national guidelines from six countries participating in an ongoing randomized controlled trial recruiting people with AHD. We extracted information addressing 18 items of AHD diagnosis and management across the following domains: [1] Definition of AHD, [2] Screening, [3] Prophylaxis, [4] Supportive care, and [5] HIV treatment. Data from national guideline documents were compared to the 2021 WHO consolidated guidelines on HIV and an agreement score was produced to evaluate extent of guideline adoption. The distribution of categories of agreement varied for the national documents. Four of the six countries addressed all 18 items (Malawi, Nigeria, Sierra Leone, Uganda). Overall agreement with the WHO 2021 guidelines ranged from 9 to 15.5 out of 18 possible points: Malawi 15.5 points, Nigeria, and Sierra Leone 14.5 points, South Africa 13.5 points, Uganda 13.0 points and Botswana with 9.0 points. Most inconsistencies were reported for the delay of antiretroviral therapy (ART) in presence of opportunistic diseases. None of the six national guidelines aligned with WHO recommendations around ART timing in patients with tuberculosis. Agreement correlated with the year of publication of the national guideline. National guidelines addressing the care of advanced HIV disease in sub-Saharan Africa are available. Besides optimal timing for start of ART in presence of tuberculosis, most national recommendations are in line with the 2021 WHO standards.
Tài liệu tham khảo
World Health Organization. HIV, Estimated number of people (all ages) living with HIV. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-people--living-with-hiv. Accessed 20 July 2023.
World Health Organization. HIV, Number of people dying from HIV-related causes. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/number-of-deaths-due-to-hiv-aids. Accessed 20 July 2023.
Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2017
Manosuthi W, Charoenpong L, Santiwarangkana C. A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting. AIDS Res Ther. 2021;18(1):71.
Leeme TB, Mine M, Lechiile K, Mulenga F, Mosepele M, Mphoyakgosi T, et al. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana. HIV Med. 2021;22(1):1–10.
Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox MP, et al. Persistent high burden of advanced HIV disease among patients seeking care in South Africa’s National HIV Program: data from a nationwide laboratory cohort. Clin Infect Dis. 2018;66:S111–7.
Lamp K, McGovern S, Fong Y, Atem CD, Nfetam JBE, Nzuobontane D, et al. Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries. PLoS ONE. 2020;15(1):e0226987.
Stoger L, Katende A, Mapesi H, Kalinjuma AV, van Essen L, Klimkait T, et al. Persistent high burden and mortality associated with advanced HIV disease in rural tanzania despite uptake of World Health Organization “Test and Treat” guidelines. Open Forum Infect Dis. 2022;9(12):ofac611.
Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G, et al. The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa. Clin Infect Dis. 2018;66:S118–25.
Boyd AT, Oboho I, Paulin H, Ali H, Godfrey C, Date A, et al. Addressing advanced HIV disease and mortality in global HIV programming. AIDS Res Ther. 2020;17(1):40.
Ministry of Health Republic of Botswana. Handbook of the Botswana 2016 integrated HIV clinical care guidelines. 2016.
Ministry of Health and Population Malawi. Clinical management of HIV in children and adults. 2022.
National AIDS and STIs Control Programme Federal Ministru of Health Nigeria. National Guidelines for HIV Prevention, Treatment and Care. 2020.
Republic of South Africa National Department of Health. 2023 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy and Breastfeeding, Adolescents, Children, Infants and Neonates. June 2023 Version 4: Republic of South Africa National Department of Health; 2023.
Ministry of Health and Sanitation Sierra Leone. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care in Sierra Leone. 2020.
Ministry of Health Republic of Uganda. Consolidated guidelines for the prevention and treatment of HIV in Uganda. 2018 Second Edition.
Consolidated Guidelines on HIV Prevention. Testing, treatment, service delivery and monitoring: recommendations for a Public Health Approach. Geneva: WHO Guidelines Approved by the Guidelines Review Committee; 2021.
World Health Organization. Providing care to people with advanced HIV disease who are seriously ill: policy brief. Geneva: World Health Organization; 2023.
Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377(3):233–45.
Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015;385(9983):2173–82.
Brazier E, Tymejczyk O, Zaniewski E, Egger M, Wools-Kaloustian K, Yiannoutsos CT, et al. Effects of national adoption of treat-all guidelines on pre-antiretroviral therapy (ART) CD4 testing and viral load monitoring after art initiation: a regression discontinuity analysis. Clin Infect Dis. 2021;73(6):e1273–81.
Lakoh S, Kamudumuli PS, Penney ROS, Haumba SM, Jarvis JN, Hassan AJ, et al. Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. Lancet Infect Dis. 2023;23(5):598–608.
Uthman OA, Okwundu C, Gbenga K, Volmink J, Dowdy D, Zumla A, et al. Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Ann Intern Med. 2015;163(1):32–9.
World Bank. Population, total: Worldbank; https://data.worldbank.org/indicator/SP.POP.TOTL?name_desc=false. Accessed 20 July 2023.
Fonner VA, Sands A, Figueroa C, Baggaley R, Quinn C, Jamil MS, et al. Country adherence to WHO recommendations to improve the quality of HIV diagnosis: a global policy review. BMJ Glob Health. 2020;5(5):e001939.
Izco S, Garcia-Basteiro AL, Denning DW, Boulware DR, Penn-Nicholson A, Letang E. Management of advanced HIV disease in Africa. Lancet HIV. 2023. https://doi.org/10.1016/S2352-3018(23)00078-4.
Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, et al. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa. BMC Infect Dis. 2019;19(1):261.